Center-Authored Papers

Filters: Author is Grady, William M  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Abrams JA, Appelman HD, Beer DG, Berry LD, Chak A, Falk GW, Fitzgerald RC, Ginsberg GG, Grady WM, Joshi BP et al..  2014.  Barrett's Esophagus Translational Research Network (BETRNet): The Pivotal Role of Multi-institutional Collaboration in Esophageal Adenocarcinoma Research.. Gastroenterology. 146(7):1586-90.
Adams SV, Ahnen DJ, Baron JA, Campbell PT, Gallinger S, Grady WM, Le Marchand L, Lindor NM, Potter JD, Newcomb PA.  2013.  Survival after inflammatory bowel disease-associated colorectal cancer in the Colon Cancer Family Registry.. World journal of gastroenterology : WJG. 19(21):3241-8. Abstract
Amendola LM, Dorschner MO, Robertson PD, Salama JS, Hart R, Shirts BH, Murray ML, Tokita MJ, Gallego CJ, Kim DS et al..  2015.  Actionable exomic incidental findings in 6503 participants: challenges of variant classification.. Genome research. 25(3):305-15. Abstract
Ausch C, Kim Y-H, Tsuchiya KD, Dzieciatkowski S, Washington MK, Paraskeva C, Radich JP, Grady WM.  2009.  Comparative analysis of PCR-based biomarker assay methods for colorectal polyp detection from fecal DNA.. Clinical chemistry. 55(8):1559-63. Abstract
B
Baek JY, Morris SM, Campbell J, Fausto N, Yeh MM, Grady WM.  2010.  TGF-beta inactivation and TGF-alpha overexpression cooperate in an in vivo mouse model to induce hepatocellular carcinoma that recapitulates molecular features of human liver cancer.. International journal of cancer. Journal international du cancer. 127(5):1060-71. Abstract
Borinstein SC, Conerly M, Dzieciatkowski S, Biswas S, Washington KM, Trobridge P, Henikoff S, Grady WM.  2010.  Aberrant DNA methylation occurs in colon neoplasms arising in the azoxymethane colon cancer model.. Molecular carcinogenesis. 49(1):94-103. Abstract
Bosch LJW, Luo Y, Lao VV, Snaebjornsson P, Trooskens G, Vlassenbroeck I, Mongera S, Tang W, Welcsh P, Herman JG et al..  2016.  WRN promoter CpG island hypermethylation does not predict more favorable outcomes for metastatic colorectal cancer patients treated with irinotecan-based therapy.. Clinical cancer research : an official journal of the American Association for Cancer Research. 22(18):4612-4622. Abstract
Burnett-Hartman AN, Newcomb PA, Phipps AI, Passarelli MN, Grady WM, Upton MP, Zhu L-C, Potter JD.  2012.  Colorectal endoscopy, advanced adenomas, and sessile serrated polyps: implications for proximal colon cancer.. The American journal of gastroenterology. 107(8):1213-9. Abstract
Burnett-Hartman AN, Newcomb PA, Potter JD, Passarelli MN, Phipps AI, Wurscher MA, Grady WM, Zhu L-C, Upton MP, Makar KW.  2013.  Genomic Aberrations Occurring in Subsets of Serrated Colorectal Lesions but not Conventional Adenomas.. Cancer research. 73(9):2863-72. Abstract
C
Chak A, Falk G, Grady WM, Kinnard M, Elston R, Mittal S, King JF, Willis JE, Kondru A, Brock W et al..  2009.  Assessment of familiality, obesity, and other risk factors for early age of cancer diagnosis in adenocarcinomas of the esophagus and gastroesophageal junction.. The American journal of gastroenterology. 104(8):1913-21. Abstract
Chak A, Chen Y, Vengoechea J, Canto MI, Elston R, Falk GW, Grady WM, Guda K, Kinnard M, Markowitz S et al..  2012.  Variation in Age at Cancer Diagnosis in Familial versus Nonfamilial Barrett's Esophagus.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 21(2):376-383. Abstract
Cicek MS, Lindor NM, Gallinger S, Bapat B, Hopper JL, Jenkins MA, Young J, Buchanan D, Walsh MD, Le Marchand L et al..  2011.  Quality assessment and correlation of microsatellite instability and immunohistochemical markers among population- and clinic-based colorectal tumors results from the Colon Cancer Family Registry.. The Journal of molecular diagnostics : JMD. 13(3):271-81. Abstract
Cohen SA, Yu M, Baker K, Redman M, Wu C, Heinzerling TJ, Wirtz RM, Charalambous E, Pentheroudakis G, Kotoula V et al..  2017.  The CpG island methylator phenotype is concordant between primary colorectal carcinoma and matched distant metastases.. Clinical epigenetics. 9:46. Abstract
Cohen SA, Wu C, Yu M, Gourgioti G, Wirtz R, Raptou G, Gkakou C, Kotoula V, Pentheroudakis G, Papaxoinis G et al..  2016.  Evaluation of CpG Island Methylator Phenotype as a Biomarker in Colorectal Cancer Treated With Adjuvant Oxaliplatin.. Clinical colorectal cancer. 15(2):164-169. Abstract
Cohen SA, Laurino M, Bowen DJ, Upton MP, Pritchard C, Hisama F, Jarvik G, Fichera A, Sjoding B, Bennett RL et al..  2016.  Initiation of universal tumor screening for Lynch syndrome in colorectal cancer patients as a model for the implementation of genetic information into clinical oncology practice.. Cancer. 122(3):393-401. Abstract
Cohen SA, Turner EH, Beightol MB, Jacobson A, Gooley TA, Salipante SJ, Haraldsdottir S, Smith C, Scroggins S, Tait JF et al..  2016.  Frequent PIK3CA Mutations in Colorectal and Endometrial Tumors with 2 or More Somatic Mutations in Mismatch Repair Genes.. Gastroenterology. Abstract
Conerly M, Grady WM.  2010.  Insights into the role of DNA methylation in disease through the use of mouse models.. Disease models & mechanisms. 3(5-6):290-7. Abstract
Cui J, Cai Y, Hu Y, Huang Z, Luo Y, Kaz AM, Yang Z, Chen D, Fan X, Grady WM et al..  2016.  Epigenetic silencing of TPM2 contributes to colorectal cancer progression upon RhoA activation.. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 37(9):12477-12483. Abstract
Curtius K, Wong C-J, Hazelton WD, Kaz AM, Chak A, Willis JE, Grady WM, Luebeck EG.  2016.  A Molecular Clock Infers Heterogeneous Tissue Age Among Patients with Barrett's Esophagus.. PLoS computational biology. 12(5):e1004919. Abstract
D
Dickinson BT, Kisiel J, Ahlquist DA, Grady WM.  2015.  Molecular markers for colorectal cancer screening.. Gut. Abstract
F
Fischer JM, Calabrese PP, Miller AJ, Muñoz NM, Grady WM, Shibata D, Liskay MR.  2016.  Single cell lineage tracing reveals a role for TgfβR2 in intestinal stem cell dynamics and differentiation.. Proceedings of the National Academy of Sciences of the United States of America. 113(43):12192-12197. Abstract
G
Gallego CJ, Bennette CS, Heagerty P, Comstock B, Horike-Pyne M, Hisama F, Amendola LM, Bennett RL, Dorschner MO, Tarczy-Hornoch P et al..  2014.  Comparative effectiveness of next generation genomic sequencing for disease diagnosis: Design of a randomized controlled trial in patients with colorectal cancer/polyposis syndromes.. Contemporary clinical trials. Abstract
Gallego CJ, Shirts BH, Bennette CS, Guzauskas G, Amendola LM, Horike-Pyne M, Hisama FM, Pritchard CC, Grady WM, Burke W et al..  2015.  Next-Generation Sequencing Panels for the Diagnosis of Colorectal Cancer and Polyposis Syndromes: A Cost-Effectiveness Analysis.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Abstract
Grady WM, Tewari M.  2010.  The next thing in prognostic molecular markers: microRNA signatures of cancer.. Gut. 59(6):706-8.
Grady WM, Pritchard CC.  2013.  Molecular Alterations and Biomarkers in Colorectal Cancer.. Toxicologic pathology. Abstract